Literature DB >> 21181277

Intrapituitary cytokines in Cushing's disease: do they play a role?

Agostino Paoletta1, Giorgio Arnaldi, Roberta Papa, Marco Boscaro, Giacomo Tirabassi.   

Abstract

A large body of in vitro evidence shows that cytokines influence the hypothalamic-pituitary-adrenal axis both in physiological conditions and in Cushing's disease (CD). In order to study in vivo the role of intrapituitary cytokines in CD, we assayed two cytokines known for their action on the pituitary, i.e. interleukin-1 beta (IL-1β) and interleukin-6 (IL-6), and also soluble interleukin-6 receptor (sIL-6R), important for the neural activities of IL-6, in a carefully selected sample of subjects affected by CD undergoing bilateral inferior petrosal sinus sampling. Similarly to ACTH, all cytokines basally showed a higher concentration in the ipsilateral sinus compared to the controlateral one and to that of peripheral blood; after CRH infusion, both ipsilaterally and controlaterally, IL-6 and sIL-6R values increased compared to basal ones, while IL-1β increased significantly up to 5 min after CRH and then decreased significantly compared to basal values in subsequent measurements; peripherically no significant variations in the cytokines were observed after CRH. Again similarly to ACTH, the three cytokines presented a higher increase ipsilaterally than controlaterally; moreover all three interleukins in the ipsilateral sinuses showed positive and significant correlations between their basal value and that of basal ACTH. These findings allow us to hypothesize that the central production of IL-1β and IL-6 could be involved in ACTH hypersecretion which occurs in CD: more specifically, we hypothesize that these cytokines are produced directly by the corticotroph adenoma and have the task of enhancing tumoral secretion of ACTH with an autocrine-paracrine mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21181277     DOI: 10.1007/s11102-010-0285-9

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  31 in total

Review 1.  Diagnosis and complications of Cushing's syndrome: a consensus statement.

Authors:  G Arnaldi; A Angeli; A B Atkinson; X Bertagna; F Cavagnini; G P Chrousos; G A Fava; J W Findling; R C Gaillard; A B Grossman; B Kola; A Lacroix; T Mancini; F Mantero; J Newell-Price; L K Nieman; N Sonino; M L Vance; A Giustina; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

Review 2.  Many cytokines are very useful therapeutic targets in disease.

Authors:  Marc Feldmann
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

3.  Interleukin-1 and glucocorticoid hormones integrate an immunoregulatory feedback circuit.

Authors:  A Del Rey; H Besedovsky; E Sorkin; C A Dinarello
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

4.  Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling.

Authors:  E H Oldfield; G P Chrousos; H M Schulte; M Schaaf; P E McKeever; A G Krudy; G B Cutler; D L Loriaux; J L Doppman
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

Review 5.  Corticotropin-releasing factor and interleukin-1 receptors in the brain-endocrine-immune axis. Role in stress response and infection.

Authors:  E B De Souza
Journal:  Ann N Y Acad Sci       Date:  1993-10-29       Impact factor: 5.691

6.  Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.

Authors:  R Kurotani; M Yasuda; K Oyama; N Egashira; M Sugaya; A Teramoto; R Y Osamura
Journal:  Mod Pathol       Date:  2001-08       Impact factor: 7.842

7.  Interleukin-1 beta and other cytokines stimulate adrenocorticotropin release from cultured pituitary cells of patients with Cushing's disease.

Authors:  W B Malarkey; B J Zvara
Journal:  J Clin Endocrinol Metab       Date:  1989-07       Impact factor: 5.958

8.  Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2.

Authors:  V K Singh; S J Leu
Journal:  Neurosci Lett       Date:  1990-12-11       Impact factor: 3.046

9.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

Review 10.  Regulation and role of intrapituitary IL-6 production by folliculostellate cells.

Authors:  U Renner; J Gloddek; M P Pereda; E Arzt; G K Stalla
Journal:  Domest Anim Endocrinol       Date:  1998-09       Impact factor: 2.290

View more
  4 in total

1.  ACTH-secreting pituitary microadenomas are associated with a higher prevalence of central hypothyroidism compared to other microadenoma types.

Authors:  Nestoras Mathioudakis; Sritika Thapa; Gary S Wand; Roberto Salvatori
Journal:  Clin Endocrinol (Oxf)       Date:  2012-12       Impact factor: 3.478

2.  Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas.

Authors:  S Cannavo; F Ferrau; O R Cotta; S Saitta; V Barresi; M T Cristani; A Saija; R M Ruggeri; F Trimarchi; S Gangemi
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

3.  Cushing Syndrome: The Role of MSCs in Wound Healing, Immunosuppression, Comorbidities, and Antioxidant Imbalance.

Authors:  Miriam Caffarini; Tatiana Armeni; Pamela Pellegrino; Laura Cianfruglia; Marianna Martino; Annamaria Offidani; Giovanni Di Benedetto; Giorgio Arnaldi; Anna Campanati; Monia Orciani
Journal:  Front Cell Dev Biol       Date:  2019-10-09

4.  Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing's disease.

Authors:  Takako Araki; Jutarat Sangtian; Darin Ruanpeng; Ramachandra Tummala; Brent Clark; Lynn Burmeister; Daniel Peterson; Andrew S Venteicher; Yasuhiko Kawakami
Journal:  Pituitary       Date:  2021-05-26       Impact factor: 4.107

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.